Moprolol
Moprolol ((±)-Moprolol) is an beta-adrenergic receptor blocker, which can be used for research in essential hypertension.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 5741-22-0
- Formule: C13H21NO3
- Masse moléculaire:239.31
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform Adrenergic Receptor
More
Activité biologique
|
Beta-1 adrenergic receptor |
l-Moprolol is a β-blocker L-enantiomer with low negative inotropic activity and mild intrinsic sympathetomimetic activity, which can be used effectively in systemic hypertension studies. In primary open Angle glaucoma (POAG) or ocular hypertension (OHT) models, the topical application of l-Moprolol can reduce intraocular pressure (IOP) as effectively as tiolol, and has emerged as a promising compound for the inhibition of glaucoma due to its lack of activity on bronchial muscles[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 5741-22-0
-
Masse moléculaire 239.31
-
Formule C13H21NO3
-
SMILES
OC(CNC(C)C)COC1=CC=CC=C1OC
-
Synonyms
(±)-Moprolol
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Borowiecki P, et al. Development of a novel chemoenzymatic route to enantiomerically enriched β-adrenolytic agents. A case study toward propranolol, alprenolol, pindolol, carazolol, moprolol, and metoprolol. RSC Adv. 2022 Aug 10;12(34):22150-22160. [Content Brief]
[2]. Liu J, et al. beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharmacol Ther. 2006 Jul;80(1):23-32. [Content Brief]
[3]. Rossetti L, et al. The efficacy of the combination of l-moprolol and dipivefrin in reducing the intraocular pressure in primary open-angle glaucoma or in ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1994 Nov;232(11):670-4. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Moprolol Related Classifications
HY-108306 Related Classifications
Powered by Bioz